Liposomes as potential carriers for ketorolac ophthalmic delivery: formulation and stability issues
Open Access
- 1 January 2017
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 53 (2)
Abstract
Drug delivery to treat ocular disorders locally is a challenging endeavor. Traditional ocular dosage form - eye drops - exhibits poor availability, consequently inefficient therapeutic response. The objective of the study was to formulate and characterize a ketorolac tromethamine ocular system with a prolonged release pattern based on liposomes as a vesicular carrier and to design once daily liquid preparation realizing the thermal in situ gelation principle. Liposomes were prepared by film hydration method. The influence of cholesterol concentration, pH and volume of hydration medium, and type and concentration of charging imparting agents were studied. Liposomes were characterized via, morphological examination, vesicular size, and encapsulation efficiency, and in vitro release performance, moreover its stability was assessed. The results obtained highlighted that liposomes showed a closed vesicular multi-lamellar structure. Ketorolac was successfully encapsulated within the liposomal structure in a cholesterol and charge inducing agent concentration-dependent behaviour. The dispersion of liposomes within thermosensitive Poloxamer in situ gel was able to retard the release of the drug by diffusion providing a controlled prolonged delivery. The liposomal formulations were physically stable for six months. Ketorolac tromethamine in situ liposomal gel representing an efficient alternative in terms of ocular retention and patient compliance when compared with conventional eye dropsKeywords
This publication has 26 references indexed in Scilit:
- Physiologically activated phase transition systems for improved ocular retention of ketorolac tromethamineJournal of Pharmacy and Bioallied Sciences, 2012
- Study of ocular drug delivery system using drug-loaded liposomesInternational Journal of Pharmaceutical Investigation, 2011
- Development of a liposomal nanodelivery system for nevirapineJournal of Biomedical Science, 2010
- Ocular Drug DeliveryThe AAPS Journal, 2010
- Ciprofloxacin as Ocular Liposomal HydrogelAAPS PharmSciTech, 2010
- Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessmentDrug Development and Industrial Pharmacy, 2010
- Ciprofloxacin Liposomes as Vesicular Reservoirs for Ocular Delivery: Formulation, Optimization, and In Vitro CharacterizationDrug Development and Industrial Pharmacy, 2009
- Topical Ocular Delivery of NSAIDsThe AAPS Journal, 2008
- Aqueous, oil, and ointment formulations of ketorolac: efficacy against prostaglandin E2-induced ocular inflammation and safety: A technical noteAAPS PharmSciTech, 2006
- “Medical Applications of Liposomes”: Danilo D. Lasic†, Demetrios Papahadjopoulos† (Editors), Elsevier, Amsterdam, New York; 1998, 794 pages, € 236.50 ($ 236.50), ISBN 0-444-82917-2European Journal of Pharmaceutics and Biopharmaceutics, 2002